WEBINAR LaunchBIO Larger than Life Science: Thinking Ahead - Our Regenerative Future

Description

PROMISE & POSSIBILITY: CURRENT STATE OF STEM CELL MEDICINE

The global regenerative medicine market is expected to reach $5.6 billion by 2025. Due to its wide range of applications regenerative medicine will continue to gain traction both within research institutions and with investors looking to ride the wave. But what can we expect in the next 10-years? What areas hold the most promise and who is receiving the funding? Join our panel of experts to explore the promise and possibilities of our regenerative future.

 

• Matt Bresnahan, Partner, Wilson Sonsini
• Samuel Chuang, PhD, Director, Scientific Advisory Services at Charles River Laboratories
• Westbrook Weaver, PhD, Founder and Chief Executive Officer, Tempo Therapeutics Inc.
• Karen Christman, PhD, Professor, Bioengineering, UC San Diego